ABOUT THE EXPERT

Neil P. Shah,

MD, PhD

Edward S. Ageno Distinguished Professorship in Hematology/Oncology
Professor, Department of Medicine
Program Leader, Hematopoietic Malignancies Program
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, CA 

Neil P. Shah, MD, PhD, joined the faculty at the University of California, San Francisco (UCSF) in 2006. He is presently the Edward S. Ageno Distinguished Professor in Hematology/Oncology at the UCSF School of Medicine. He also serves as leader of the Hematopoietic Malignancies Program within the UCSF Helen Diller Family Comprehensive Cancer Center, and as director of the UCSF Molecular Medicine Residency Program. He received his BS from the University of California, Berkeley and his MD and PhD degrees from the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). He remained at UCLA for his internship and residency training in internal medicine, as well as his fellowship training in hematology and oncology. 

Dr Shah performed postdoctoral research in the laboratory of Charles L. Sawyers, MD, where his translational studies led directly to the clinical investigation and the US Food and Drug Administration approval of dasatinib, a transformative therapy for patients with chronic myeloid leukemia. His laboratory efforts remain firmly rooted in molecular studies of human leukemias and attempts to translate expanding knowledge of the genetics of these diseases toward the development of more active and better-tolerated targeted therapeutics. 

CONTRIBUTING ARTICLES